Myeloma Investment Fund invests in Nammi Therapeutics, Inc.'s Series B financing
Client(s) Myeloma Investment Fund
Jones Day advised Myeloma Investment Fund in $1 million investment in Nammi Therapeutics, Inc.'s Series B financing.
Cases & Deals
Contacts
Practices
Before sending, please note:
Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.